Richard serves as the Managing Director of GrayBella Capital LLC, a Pan-European venture capital firm, investing in growth-stage technology and healthtech companies. Since 2021 he has serves as a Board member of and since 2018 he serves as Chairman of the Board of BC Platforms. Before this, Richard was Executive Chairman of the Board of ViS Research Inc., acquired by IMS Health and a Board Director of Rexahn Pharmaceuticals, Inc. (NYSE: RNN).

Mr. Kivel’s executive management experience also includes a Senior Management position at Bridgewater Associates, and two Chief Executive Officer positions: TheraGenetics and MolecularWare (both companies were acquired). He has served various roles at the Massachusetts Institute of Technology, including as the Chairman of the MIT Enterprise Forum, a Board member of the MIT Alumni Association, he is a regular Lecturer at MIT. He is also a Trustee of Bankinter Innovation Foundation, technology think tank based in Madrid.

Richard Kivel

Managing Director


Also speaking: